Jinhao Zeng

2.6k total citations · 1 hit paper
114 papers, 1.6k citations indexed

About

Jinhao Zeng is a scholar working on Molecular Biology, Pharmacology and Epidemiology. According to data from OpenAlex, Jinhao Zeng has authored 114 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 22 papers in Pharmacology and 18 papers in Epidemiology. Recurrent topics in Jinhao Zeng's work include Drug-Induced Hepatotoxicity and Protection (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Jinhao Zeng is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Helicobacter pylori-related gastroenterology studies (11 papers). Jinhao Zeng collaborates with scholars based in China, Germany and France. Jinhao Zeng's co-authors include Xiao Ma, Qichao Hu, Xinyu Deng, Yanling Zhao, Maoyuan Zhao, Yubing Li, Xiaolin Xiao, Jianyuan Tang, Nianzhi Chen and Yuan Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Jinhao Zeng

106 papers receiving 1.6k citations

Hit Papers

Diabetic nephropathy: Focusing on pathological signals, c... 2023 2026 2024 2025 2023 25 50 75

Peers

Jinhao Zeng
Yan Yang China
Young‐Rae Lee South Korea
Seong Min Kim South Korea
Ravi P. Sahu United States
Yoosik Yoon South Korea
Jinhao Zeng
Citations per year, relative to Jinhao Zeng Jinhao Zeng (= 1×) peers Chi Teng Vong

Countries citing papers authored by Jinhao Zeng

Since Specialization
Citations

This map shows the geographic impact of Jinhao Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinhao Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinhao Zeng more than expected).

Fields of papers citing papers by Jinhao Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinhao Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinhao Zeng. The network helps show where Jinhao Zeng may publish in the future.

Co-authorship network of co-authors of Jinhao Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Jinhao Zeng. A scholar is included among the top collaborators of Jinhao Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinhao Zeng. Jinhao Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Ni, Jiyuan, et al.. (2025). Astragaloside IV: A Promising Drug to Prevent the Transition from Colitis to Colorectal Cancer. The American Journal of Chinese Medicine. 53(4). 1065–1091. 4 indexed citations
5.
Nian, Qing, et al.. (2025). Targeting Myeloperoxidase in Disease Pathogenesis: Emerging Roles of Natural Products in Therapeutic Modulation. The American Journal of Chinese Medicine. 53(7). 1983–2019. 1 indexed citations
6.
Hu, Sihan, Huiling Xiong, Xiaohua Lu, et al.. (2025). The efficacy and toxicity equilibrium of emodin for liver injury: A bidirectional meta-analysis and machine learning. Phytomedicine. 142. 156650–156650.
7.
Chen, Shuang, et al.. (2024). The dynamic equilibrium between the protective and toxic effects of matrine in the development of liver injury: a systematic review and meta-analysis. Frontiers in Pharmacology. 15. 1315584–1315584. 4 indexed citations
8.
Deng, Xinyu, Yubing Li, Yuan Chen, et al.. (2024). Paeoniflorin protects hepatocytes from APAP-induced damage through launching autophagy via the MAPK/mTOR signaling pathway. Cellular & Molecular Biology Letters. 29(1). 119–119. 33 indexed citations
9.
Nian, Qing, et al.. (2024). Unraveling the pathogenesis of myelosuppression and therapeutic potential of natural products. Phytomedicine. 132. 155810–155810. 7 indexed citations
10.
Nian, Qing, et al.. (2024). Multifaceted functions of the Wilms tumor 1 protein: From its expression in various malignancies to targeted therapy. Translational Oncology. 52. 102237–102237. 2 indexed citations
11.
Zhang, Jin, et al.. (2024). Targeting neutrophil extracellular traps: A novel strategy in hematologic malignancies. Biomedicine & Pharmacotherapy. 173. 116334–116334. 5 indexed citations
12.
Wang, Qian, Xinyu Xiao, Siyan Chen, et al.. (2024). Dietary factors and the risk of atopic dermatitis: a Mendelian randomisation study. British Journal Of Nutrition. 131(11). 1873–1882. 2 indexed citations
13.
Hu, Qichao, Xinyu Deng, Yuan Chen, et al.. (2023). Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives. Phytotherapy Research. 37(6). 2661–2692. 14 indexed citations
14.
Nian, Qing, Yihui Li, Jingwei Li, et al.. (2023). U2AF1 in various neoplastic diseases and relevant targeted therapies for malignant cancers with complex mutations (Review). Oncology Reports. 51(1). 6 indexed citations
15.
Liang, Dan, Lu Liu, Maoyuan Zhao, et al.. (2023). Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway. International Immunopharmacology. 124(Pt A). 110902–110902. 11 indexed citations
16.
Zhang, Lanlan, Maoyuan Zhao, Wenhao Liao, et al.. (2023). Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy. Phytotherapy Research. 37(5). 2036–2050. 16 indexed citations
17.
Zhao, Ziyi, Xiaomei Zhang, Yanlei Guo, et al.. (2022). Pull the plug: Anti‐angiogenesis potential of natural products in gastrointestinal cancer therapy. Phytotherapy Research. 36(9). 3371–3393. 14 indexed citations
18.
Jiang, Yinxiao, et al.. (2022). Evidence construction of Chinese herbal formulae for the treatment of H. pylori positive peptic ulcer: A Bayesian network Meta-analysis. Phytomedicine. 105. 154327–154327. 1 indexed citations
19.
Zeng, Jinhao, Lijuan Wen, Ting Xia, et al.. (2021). Assessment of clinical competency among TCM medical students using standardized patients of traditional Chinese medicine: A 5-year prospective randomized study. Integrative Medicine Research. 11(2). 100804–100804. 5 indexed citations
20.
Jiang, Yifang, Fengming You, Jie Zhu, et al.. (2019). Cryptotanshinone Ameliorates Radiation-Induced Lung Injury in Rats. Evidence-based Complementary and Alternative Medicine. 2019. 1–14. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026